YUEYANG QIKE SUPPLY CHAIN MANAGEMENT CO., LTD – Trademark Portfolio
Entity Type: 16
YUEYANG QIKE SUPPLY CHAIN MANAGEMENT CO., LTD holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 4 filings in this category. The portfolio also extends into Class 21 (Housewares) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include BGAID, CTONG, and ZMIAO. The owner is based in YUEYANG, HUNAN.
CHENGLINGJI COMPREHENSIVE BONDED ZONE
ROOM 605, INTERNATIONAL TRADE BONDED LOGISTICS, CENTER
YUEYANG, HUNAN , CN
Showing of trademarks Trademarks
Trademark Classifications
YUEYANG QIKE SUPPLY CHAIN MANAGEMENT CO., LTD's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Frequently Asked Questions
How many trademarks does YUEYANG QIKE SUPPLY CHAIN MANAGEMENT CO., LTD have?
YUEYANG QIKE SUPPLY CHAIN MANAGEMENT CO., LTD has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned, 1 cancelled.
What trademark classes does YUEYANG QIKE SUPPLY CHAIN MANAGEMENT CO., LTD file in?
YUEYANG QIKE SUPPLY CHAIN MANAGEMENT CO., LTD files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 21 (Housewares). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are YUEYANG QIKE SUPPLY CHAIN MANAGEMENT CO., LTD's most well-known trademarks?
YUEYANG QIKE SUPPLY CHAIN MANAGEMENT CO., LTD's registered trademark portfolio includes well-known marks such as BGAID, CTONG, and ZMIAO. These are among 3 currently registered trademarks in the portfolio.
What is YUEYANG QIKE SUPPLY CHAIN MANAGEMENT CO., LTD's trademark registration success rate?
YUEYANG QIKE SUPPLY CHAIN MANAGEMENT CO., LTD has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.